The estimated Net Worth of John L. Killmer is at least $446 Tysiąc dollars as of 5 September 2019. Mr. Killmer owns over 500 units of American Vanguard stock worth over $273,636 and over the last 16 years he sold AVD stock worth over $0. In addition, he makes $172,000 as Lead Independent Director at American Vanguard.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Killmer AVD stock SEC Form 4 insiders trading
John has made over 1 trades of the American Vanguard stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 500 units of AVD stock worth $7,610 on 5 September 2019.
The largest trade he's ever made was buying 500 units of American Vanguard stock on 5 September 2019 worth over $7,610. On average, John trades about 29 units every 0 days since 2008. As of 5 September 2019 he still owns at least 45,080 units of American Vanguard stock.
You can see the complete history of Mr. Killmer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Killmer biography
Dr. John L. Killmer Ph.D. serves as Lead Independent Director of the Company. In June 2011 Mr. Killmer was elected as the Company’s lead independent director and continues to serve in that capacity. During his career, Mr. Killmer was responsible for Global Marketing, Product and Supply Chain Management for Arysta LifeSciences Corporation (“Arysta”), a large privately held crop protection and life science company, from November 2004 through June 2008. At Arysta, Mr. Killmer had global responsibility for marketing and product management and, in addition, was responsible for global supply chain management. From 1980 to 2004 he served in various capacities with Monsanto Company (“Monsanto”) including three years as President of Monsanto, Greater China from 2001 to 2003. Since December 2014, Mr. Killmer has served as a member of the board of directors of RNAgri, Inc., a privately-held corporation involved in the development of RNAi technology. Mr. Killmer possesses a combination of considerable technical expertise and business acumen. A trained scientist, he began his professional career focusing on technology and ascended the corporate ladder with increasing profit responsibility. He served as pro-tem Director of Technology for the Company from March 2009 through December, 2010, during which time he evaluated the Company’s technology infrastructure and added multiple resources (both people and equipment) to help enhance the Company’s domestic manufacturing and process and formulation technology.
What is the salary of John Killmer?
As the Lead Independent Director of American Vanguard, the total compensation of John Killmer at American Vanguard is $172,000. There are 13 executives at American Vanguard getting paid more, with Eric Wintemute having the highest compensation of $1,954,940.
How old is John Killmer?
John Killmer is 70, he's been the Lead Independent Director of American Vanguard since 2019. There are 2 older and 17 younger executives at American Vanguard. The oldest executive at American Vanguard Corp. is Alfred Ingulli, 78, who is the Independent Director.
What's John Killmer's mailing address?
John's mailing address filed with the SEC is 4695 MACARTHUR COURT, STE 1200, , NEWPORT BEACH, CA, 92660.
Insiders trading at American Vanguard
Over the last 21 years, insiders at American Vanguard have traded over $50,676,664 worth of American Vanguard stock and bought 629,726 units worth $5,875,021 . The most active insiders traders include Glenn A Wintemute, Eric G Wintemute oraz Herbert A Kraft. On average, American Vanguard executives and independent directors trade stock every 29 days with the average trade being worth of $98,474. The most recent stock trade was executed by Keith M Cruiser Capital Adv... on 30 August 2024, trading 136,492 units of AVD stock currently worth $790,289.
What does American Vanguard do?
american vanguard corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the united states and internationally. the company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. it also markets and distributes end-use chemical and biological products for crop applications; distributes chemicals for greenhouse and nursery production markets; and offers formulations, such as pcnb, chlorothalonil, and propiconazole under the ffii and ffiii names. the company distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. american vanguard corporation was founded in 196
What does American Vanguard's logo look like?
Complete history of Mr. Killmer stock trades at American Vanguard
American Vanguard executives and stock owners
American Vanguard executives and other stock owners filed with the SEC include:
-
Eric Wintemute,
Chairman of the Board, Chief Executive Officer -
Eric G. Wintemute,
Chairman & CEO -
David Johnson,
Chief Financial Officer, Vice President, Treasurer -
Ulrich Trogele,
Executive Vice President, Chief Operating Officer of AMVAC Chemical Corporation -
Timothy Donnelly,
Chief Administrative Officer, General Counsel, Secretary -
Dr. Ulrich G. Trogele Ph.D.,
COO & Exec. VP -
Peter Eilers,
Managing Director, Amvac Netherlands BV -
Timothy J. Donnelly Esq.,
Gen. Counsel, Chief Admin. Officer & Sec. -
David T. Johnson,
VP, CFO & Treasurer -
Anthony Hendrix,
Senior Vice President - Crop Sales for U.S. & Canada -
Timothy J. Donnelly,
Gen. Counsel, Chief Admin. Officer & Sec. -
Peter E. Eilers,
Managing Director of AMVAC Netherlands BV -
Anthony Hendrix,
Sr. VP of Crop Sales for U.S. & Canada -
John Killmer,
Lead Independent Director -
Alfred Ingulli,
Independent Director -
Morton Erlich,
Independent Director -
Lawrence Clark,
Independent Director -
M. Esmail Zirakparvar,
Independent Director -
Scott Baskin,
Independent Director -
Debra Edwards,
Independent Director -
Emer Gunter,
Independent Director -
William Kuser,
Director of Investor Relations -
James Thompson,
Director of Bus. Devel., Portfolio Management Biologicals & Non-Crop -
Robert F. Gilbane,
Pres of Gemchem Inc -
Smith Cindy Baker,
See Remarks -
Jong Ad De,
MD AMVAC Netherlands BV -
John Rizzi,
VP Operations (AMVAC) -
Anne Turnbough,
See Remarks -
Steven D Macicek,
-
Suneet Ranganath,
See Remarks -
Peter Porpiglia,
See Remarks -
Jean Pougnier,
VP Business Dev. & Marketing -
Brett R Meinsen,
VICE PRESIDENT -
Mark H Blincoe,
VP/Chief Adm. Officer -
Jay R Harris,
Director -
Carl R Soderlind,
Director -
Keith M Cruiser Capital Adv...,
-
James Lehman,
Vice Pres of Sales Amvac Chem -
Glen D Johnson,
Sr.VP AMVAC Chem. Corp. -
Jerome L Coben,
Director -
Irving J Thau,
Director -
Herbert A Kraft,
Director -
Glenn A Wintemute,
Director -
Trevor Thorley,
COO & EVP of Amvac Chemical -
James A Barry,
Sr. VP, CFO & Sec/Trsr -
Robert F Gilbane,
President of GemChem, Inc. -
Christopher Hildreth,
Sr. VP of AMVAC Chemical Corp. -
John B Miles,
Director -
Doug Ashmore,
VICE PRESIDENT MFG- AMVAC -
Johann Venter,
See Remarks -
Patrick E Gottschalk,
-
Marisol Angelini,
-
Shayne M Wetherall,
CEO, AMGUARD -
Andrew B Naughton,
V.P., Director of Technology -
Keith M Rosenbloom,
-
Mark R Bassett,
-
John Mason Bennett,
VP US Crop Sales